Oncology

1. In this individual-based modeling study, fewer cervical cancer screens for HPV-vaccinated women were the most cost-effective strategy. 2. Fewer...

1. This randomized controlled trial found that, in patients with hormone-receptor-positive, HER2-positive metastatic breast cancer, the addition of palbociclib to...

1. Among patients with previously untreated programmed death-ligand 1 positive, triple-negative breast cancer, first-line sacituzumab govitecan plus pembrolizumab significantly prolonged...

1. AstraZeneca is acquiring Modella AI to embed multimodal foundation models into oncology R&D and strengthen biomarker driven trial strategy....

NVIDIA and Lilly put $1B behind AI as core drug infrastructure During the JPMorgan Healthcare Conference week in mid January...

1. New FDA communication introduces a more flexible, risk‑based chemistry, manufacturing, and controls (CMC) framework for cell and gene therapies,...

1. Surgery-induced weight loss was associated with lower cancer incidence and mortality rates in women with obesity, but not men....

1. In this cohort study, a novel prognostic model was developed to estimate prostate cancer-specific mortality (PCSM) while accounting for...

1. In patients with advanced cancer who are not hypoxemic, high-flow nasal therapy using room air and simple fan therapy...

1. Among patients with high-risk, early-stage triple-negative breast cancer, the addition of carboplatin to a standard anthracycline/taxane adjuvant chemotherapy regimen...